Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

McNaughton AL., Paton RS., Edmans M., Youngs J., Wellens J., Phalora P., Fyfe A., Belij-Rammerstorfer S., Bolton JS., Ball J., Carnell GW., Dejnirattisai W., Dold C., Eyre DW., Hopkins P., Howarth A., Kooblall K., Klim H., Leaver S., Lee LN., López-Camacho C., Lumley SF., Macallan DC., Mentzer AJ., Provine NM., Ratcliff J., Slon-Compos J., Skelly D., Stolle L., Supasa P., Temperton N., Walker C., Wang B., Wyncoll D., Simmonds P., Lambe T., Baillie JK., Semple MG., Openshaw PJM., Obolski U., Turner M., Carroll M., Mongkolsapaya J., Screaton G., Kennedy SH., Jarvis L., Barnes E., Dunachie S., Lourenço J., Matthews PC., Bicanic T., Klenerman P., Gupta S., Thompson CP.

DOI

10.1172/jci.insight.156372

Type

Journal article

Journal

JCI Insight

Publisher

American Society for Clinical Investigation

Publication Date

08/07/2022

Volume

7

Permalink Original publication